New search Hide text from Guidelines
A ALIMENTARY TRACT AND METABOLISMA02 DRUGS FOR ACID RELATED DISORDERS
A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
Peptic ulcer includes ulcers in the oesophagus, stomach or duodenum.
Combinations with H2-receptor antagonists are classified in A02B.
See also A03 - Drugs for functional gastrointestinal disorders.
Antacids in combination with liquorice root or linseed are classified in A02A - Antacids.
Combinations with NSAIDs are classified in M01A.
A02BA H2-receptor antagonists
Ranitidine bismuth citrate is classified here, whereas other bismuth salts are classified in A02BX.
| The DDDs are based on treatment of peptic ulcers. |
A02BB Prostaglandins
Misoprostol low strength tablets (25 mcg) used for induction of labour are classified in G02AD06.
A02BC Proton pump inhibitors
Proton pump inhibitors in combination with domperidone are classified here in 50-levels.
Potassium-competitive acid blockers e.g. vonoprazan are classified in this group.
| The DDDs are based on treatment of gastro-oesophageal reflux disease. |
A02BD Combinations for eradication of Helicobacter pylori
This group comprises fixed combination packages.
| The DDDs for combination packages in this group are given a fixed dose DDD, e.g. 6 tablets per day gives a DDD = 6 UD. |
A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
Ranitidine bismuth citrate is classified in A02BA.
Alginic acid in combination with antacids (e.g. aluminium hydroxide, calcium carbonate) is given the code A02BX13.
| The DDD for alginic acid in combination with antacids (A02BX13) is given in a fixed doses (10 tablets = 10 UD; 50 ml mixture = 10 UD). |
Last updated: 2024-01-26